Cargando…
Effects of delayed cord clamping at different time intervals in late preterm and term neonates: a randomized controlled trial
Delayed cord clamping (DCC) at delivery has well-recognized benefits; however, current scientific guidelines lack uniformity in its definition. This parallel-group, three-arm assessor-blinded randomized controlled trial compared the effects of three different timings of DCC at 30, 60, and 120 s on v...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243262/ https://www.ncbi.nlm.nih.gov/pubmed/37278737 http://dx.doi.org/10.1007/s00431-023-05053-6 |
_version_ | 1785054391754031104 |
---|---|
author | Chaudhary, Pankaj Priyadarshi, Mayank Singh, Poonam Chaurasia, Suman Chaturvedi, Jaya Basu, Sriparna |
author_facet | Chaudhary, Pankaj Priyadarshi, Mayank Singh, Poonam Chaurasia, Suman Chaturvedi, Jaya Basu, Sriparna |
author_sort | Chaudhary, Pankaj |
collection | PubMed |
description | Delayed cord clamping (DCC) at delivery has well-recognized benefits; however, current scientific guidelines lack uniformity in its definition. This parallel-group, three-arm assessor-blinded randomized controlled trial compared the effects of three different timings of DCC at 30, 60, and 120 s on venous hematocrit and serum ferritin levels in late preterm and term neonates not requiring resuscitation. Eligible newborns (n = 204) were randomized to DCC 30 (n = 65), DCC 60 (n = 70), and DCC 120 (n = 69) groups immediately after delivery. The primary outcome variable was venous hematocrit at 24 ± 2 h. Secondary outcome variables were respiratory support, axillary temperature, vital parameters, incidences of polycythemia, neonatal hyperbilirubinemia (NNH), need and duration of phototherapy, and postpartum hemorrhage (PPH). Additionally, serum ferritin levels, the incidence of iron deficiency, exclusive breastfeeding (EBF) rate, and anthropometric parameters were assessed during post-discharge follow-up at 12 ± 2 weeks. Over one-third of the included mothers were anemic. DCC 120 was associated with a significant increase in the mean hematocrit by 2%, incidence of polycythemia, and duration of phototherapy, compared to DCC30 and DCC60; though the incidence of NNH and need for phototherapy was similar. No other serious neonatal or maternal adverse events including PPH were observed. No significant difference was documented in serum ferritin, incidences of iron deficiency, and growth parameters at 3 months even in the presence of a high EBF rate. Conclusion: The standard recommendation of DCC at 30–60 s may be considered a safe and effective intervention in the busy settings of low-middle-income countries with a high prevalence of maternal anemia. Trial registration: Clinical trial registry of India (CTRI/2021/10/037070). |
format | Online Article Text |
id | pubmed-10243262 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-102432622023-06-07 Effects of delayed cord clamping at different time intervals in late preterm and term neonates: a randomized controlled trial Chaudhary, Pankaj Priyadarshi, Mayank Singh, Poonam Chaurasia, Suman Chaturvedi, Jaya Basu, Sriparna Eur J Pediatr Research Delayed cord clamping (DCC) at delivery has well-recognized benefits; however, current scientific guidelines lack uniformity in its definition. This parallel-group, three-arm assessor-blinded randomized controlled trial compared the effects of three different timings of DCC at 30, 60, and 120 s on venous hematocrit and serum ferritin levels in late preterm and term neonates not requiring resuscitation. Eligible newborns (n = 204) were randomized to DCC 30 (n = 65), DCC 60 (n = 70), and DCC 120 (n = 69) groups immediately after delivery. The primary outcome variable was venous hematocrit at 24 ± 2 h. Secondary outcome variables were respiratory support, axillary temperature, vital parameters, incidences of polycythemia, neonatal hyperbilirubinemia (NNH), need and duration of phototherapy, and postpartum hemorrhage (PPH). Additionally, serum ferritin levels, the incidence of iron deficiency, exclusive breastfeeding (EBF) rate, and anthropometric parameters were assessed during post-discharge follow-up at 12 ± 2 weeks. Over one-third of the included mothers were anemic. DCC 120 was associated with a significant increase in the mean hematocrit by 2%, incidence of polycythemia, and duration of phototherapy, compared to DCC30 and DCC60; though the incidence of NNH and need for phototherapy was similar. No other serious neonatal or maternal adverse events including PPH were observed. No significant difference was documented in serum ferritin, incidences of iron deficiency, and growth parameters at 3 months even in the presence of a high EBF rate. Conclusion: The standard recommendation of DCC at 30–60 s may be considered a safe and effective intervention in the busy settings of low-middle-income countries with a high prevalence of maternal anemia. Trial registration: Clinical trial registry of India (CTRI/2021/10/037070). Springer Berlin Heidelberg 2023-06-06 /pmc/articles/PMC10243262/ /pubmed/37278737 http://dx.doi.org/10.1007/s00431-023-05053-6 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Research Chaudhary, Pankaj Priyadarshi, Mayank Singh, Poonam Chaurasia, Suman Chaturvedi, Jaya Basu, Sriparna Effects of delayed cord clamping at different time intervals in late preterm and term neonates: a randomized controlled trial |
title | Effects of delayed cord clamping at different time intervals in late preterm and term neonates: a randomized controlled trial |
title_full | Effects of delayed cord clamping at different time intervals in late preterm and term neonates: a randomized controlled trial |
title_fullStr | Effects of delayed cord clamping at different time intervals in late preterm and term neonates: a randomized controlled trial |
title_full_unstemmed | Effects of delayed cord clamping at different time intervals in late preterm and term neonates: a randomized controlled trial |
title_short | Effects of delayed cord clamping at different time intervals in late preterm and term neonates: a randomized controlled trial |
title_sort | effects of delayed cord clamping at different time intervals in late preterm and term neonates: a randomized controlled trial |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243262/ https://www.ncbi.nlm.nih.gov/pubmed/37278737 http://dx.doi.org/10.1007/s00431-023-05053-6 |
work_keys_str_mv | AT chaudharypankaj effectsofdelayedcordclampingatdifferenttimeintervalsinlatepretermandtermneonatesarandomizedcontrolledtrial AT priyadarshimayank effectsofdelayedcordclampingatdifferenttimeintervalsinlatepretermandtermneonatesarandomizedcontrolledtrial AT singhpoonam effectsofdelayedcordclampingatdifferenttimeintervalsinlatepretermandtermneonatesarandomizedcontrolledtrial AT chaurasiasuman effectsofdelayedcordclampingatdifferenttimeintervalsinlatepretermandtermneonatesarandomizedcontrolledtrial AT chaturvedijaya effectsofdelayedcordclampingatdifferenttimeintervalsinlatepretermandtermneonatesarandomizedcontrolledtrial AT basusriparna effectsofdelayedcordclampingatdifferenttimeintervalsinlatepretermandtermneonatesarandomizedcontrolledtrial |